rs765649978

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 3P and 6B. PM1PP2BP4_ModerateBS2

The NM_001999.4(FBN2):ā€‹c.3805A>Gā€‹(p.Ser1269Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000039 ( 0 hom., cov: 32)
Exomes š‘“: 0.000040 ( 0 hom. )

Consequence

FBN2
NM_001999.4 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1O:1

Conservation

PhyloP100: 0.116
Variant links:
Genes affected
FBN2 (HGNC:3604): (fibrillin 2) The protein encoded by this gene is a component of connective tissue microfibrils and may be involved in elastic fiber assembly. Mutations in this gene cause congenital contractural arachnodactyly. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM1
In a disulfide_bond (size 13) in uniprot entity FBN2_HUMAN there are 5 pathogenic changes around while only 0 benign (100%) in NM_001999.4
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), FBN2. . Gene score misZ 1.5491 (greater than the threshold 3.09). Trascript score misZ 3.2752 (greater than threshold 3.09). GenCC has associacion of gene with familial thoracic aortic aneurysm and aortic dissection, carpal tunnel syndrome, macular degeneration, early-onset, congenital contractural arachnodactyly.
BP4
Computational evidence support a benign effect (MetaRNN=0.08882663).
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FBN2NM_001999.4 linkuse as main transcriptc.3805A>G p.Ser1269Gly missense_variant 29/65 ENST00000262464.9
FBN2XM_017009228.3 linkuse as main transcriptc.3652A>G p.Ser1218Gly missense_variant 28/64

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FBN2ENST00000262464.9 linkuse as main transcriptc.3805A>G p.Ser1269Gly missense_variant 29/651 NM_001999.4 P1P35556-1

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152248
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000438
AC:
11
AN:
251320
Hom.:
0
AF XY:
0.0000442
AC XY:
6
AN XY:
135814
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000397
AC:
58
AN:
1461864
Hom.:
0
Cov.:
33
AF XY:
0.0000344
AC XY:
25
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000468
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152248
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000981
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMay 27, 2022Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; Although located in a calcium-binding EGF-like domain of the FBN2 gene, it does not substitute or introduce a cysteine residue (Callewaert et al., 2008; Frederic et al., 2009); This variant is associated with the following publications: (PMID: 19006240, 18767143) -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJun 01, 2019- -
Congenital contractural arachnodactyly Benign:1Other:1
Likely benign, criteria provided, single submitterclinical testingInvitaeOct 25, 2023- -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpreted as Uncertain significance and reported on 12-01-2015 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 30, 2019The p.S1269G variant (also known as c.3805A>G), located in coding exon 29 of the FBN2 gene, results from an A to G substitution at nucleotide position 3805. The serine at codon 1269 is replaced by glycine, an amino acid with similar properties, and is located in the located in cbEGF-like #16 domain. This amino acid position is well conserved in available vertebrate species; however, glycine is the reference amino acid in other vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to create a new alternate splice donor site; however, direct evidence is unavailable. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.091
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Benign
0.20
T;.;T;T;T
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.72
T;.;.;T;T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.089
T;T;T;T;T
MetaSVM
Uncertain
-0.044
T
MutationAssessor
Benign
0.22
N;.;N;.;.
MutationTaster
Benign
0.98
D;N;N;N
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.68
N;.;N;N;N
REVEL
Uncertain
0.31
Sift
Benign
0.59
T;.;T;T;T
Sift4G
Benign
0.51
.;.;.;T;T
Polyphen
0.0010
B;.;B;.;B
Vest4
0.10
MutPred
0.47
Loss of phosphorylation at S1269 (P = 0.0903);.;Loss of phosphorylation at S1269 (P = 0.0903);.;.;
MVP
0.47
MPC
0.22
ClinPred
0.054
T
GERP RS
4.1
Varity_R
0.040
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs765649978; hg19: chr5-127671189; API